Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Fatigue

NCT00227617 2023-05-22

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Lung Neoplasms, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

NCT05001724 2023-04-25

KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent

Phase 2/3 Terminated

16 enrolled

Thoracic

Advanced Non-small Cell Lung Cancer

NCT03870152 2022-10-31

EARL

Phase 2/3 Terminated

13 enrolled

Thoracic

Lung Cancer Squamous Cell

NCT01774578 2020-05-28

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Phase 2/3 Terminated

135 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT01902823 2019-12-13

Effect of Cancer Nurse Navigators on Patient Outcomes

Phase 2/3 Terminated

16 enrolled

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT02186301 2019-05-07

EGFR

Phase 2/3 Terminated

100 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT01907100 2019-03-18

Nintedanib (BIBF 1120) in Mesothelioma

Phase 2/3 Terminated

545 enrolled 15 charts

Other solid neoplasmThoracic

Mesothelioma

NCT01446874 2018-11-08

POPP

Phase 2/3 Terminated

150 enrolled 11 charts

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT01208064 2018-07-12

Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy

Phase 2/3 Terminated

102 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02326285 2018-01-23

NeoIntercal

Phase 2/3 Terminated

1 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01319669 2017-03-03

Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

Phase 2/3 Terminated

11 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01383148 2017-01-05

TIME

Phase 2/3 Terminated

222 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01348126 2015-11-05

GALAXY

Phase 2/3 Terminated

385 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01580618 2015-01-06

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Phase 2/3 Terminated

20 enrolled 11 charts

Thoracic

Neoplasms, Pleural Effusion

NCT01761747 2014-12-23

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Phase 2/3 Terminated

3 enrolled 9 charts

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00332280 2013-03-20

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Phase 2/3 Terminated

67 enrolled

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT00127387 2012-06-26

Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

Phase 2/3 Terminated

54 enrolled

GenitourinarySarcomaThoracic

Bone Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

NCT00516685 2011-09-30

NSCLC

Phase 2/3 Terminated

230 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent

EARL

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Effect of Cancer Nurse Navigators on Patient Outcomes

EGFR

Nintedanib (BIBF 1120) in Mesothelioma

POPP

Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy

NeoIntercal

Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

TIME

GALAXY

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

NSCLC